EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predictive value of primary gross tumor volume measured by MRI in response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Junbiao Li, Yuduo Wu, Shaoping Ye, Cuiying Fan, Yanping Lin, Dianhua Yang, Xiaoyi Xia, Yajing Kang, Dehao Liu, Junxin Wu

Journal of Applied Clinical Medical Physics · 2026

DOI: 10.1002/acm2.70601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2026. Verfasst von Junbiao Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Third Hospital of Xiamen, Xiamen, China. Hauptthemen laut MEDLINE: Rectal Neoplasms, Magnetic Resonance Imaging, Neoadjuvant Therapy, Chemoradiotherapy. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Clinical Research Center for Radiation and Therapy of Digestive, Respiratory and Genitourinary Malignancies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neoadjuvant chemoradiotherapy (nCRT) is a standard treatment for locally advanced rectal cancer (LARC), yet individual tumor regression response varies considerably.

Purpose

This study aimed to identify clinical factors linked to tumor regression grade (TRG) after nCRT in LARC and to evaluate MRI‐measured primary gross tumor volume (pGTV) as a predictor of TRG.

Methods

We retrospectively analyzed 123 patients with LARC who underwent nCRT followed by total mesorectal excision (TME) and had pathologically confirmed LARC between 2014 and 2018. The pGTV was measured using MRI. Univariate and multivariate logistic regression analyses were performed to identify independent predictors of TRG. Additionally, the receiver operating characteristic (ROC) curve was employed to calculate the area under the curve (AUC) for pGTV and to determine its optimal cut‐off value in predicting TRG.

Results

The study cohort comprised 52 patients in the favorable TRG group and 71 patients in the unfavorable TRG group. Both univariate and multivariate logistic regression analyses revealed that a smaller pGTV was an independent predictor of improved tumor regression ( p < 0.001). No other clinical factors were significantly associated with TRG in the multivariate analysis. The ROC curve analysis showed that a pGTV cut‐off value of 49.25 cm 3 yielded an AUC of 0.712 ( p < 0.001), effectively distinguishing between the favorable and unfavorable response groups.

Conclusions

MRI‐measured pGTV shows promise as a biomarker for predicting TRG after nCRT in LARC, potentially aiding pre‐treatment risk assessment. While this preliminary evidence from a retrospective, single‐center cohort requires confirmation in prospective, large‐scale studies, it provides a rationale for incorporating quantitative tumor volumetry into future research on individualized treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsMagnetic Resonance ImagingNeoadjuvant TherapyChemoradiotherapyHumansRetrospective StudiesFemaleTumor BurdenMiddle AgedMaleAgedPrognosisROC CurveAdultRadiotherapy DosageRadiotherapy Planning, Computer-AssistedRadiotherapy, Intensity-ModulatedPredictive Value of Tests

Stichwörter der Autor:innen

locally advanced rectal cancerneoadjuvant radiotherapytumor regression gradetumor volume

Autor:innen und Institutionen

  • Department of Oncology, The Third Hospital of Xiamen, Xiamen, China.
  • Medical Physics Graduate Program, Duke Kunshan University, Kunshan, China.
  • School of Basic Medical Sciences, Fujian Medical University, Fujian, China.
  • Department of Radiology, School of Medicine, The First Affiliated Hospital of Xiamen University, Xiamen University, Xiamen, China.
  • Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.

Förderung

  • Fujian Clinical Research Center for Radiation and Therapy of Digestive, Respiratory and Genitourinary Malignancies

Zitieren

APA

Li, J., Wu, Y., Ye, S., Fan, C., Lin, Y., Yang, D., Xia, X., Kang, Y., Liu, D., & Wu, J. (2026). Predictive value of primary gross tumor volume measured by MRI in response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70601

Vancouver

Li J, Wu Y, Ye S, Fan C, Lin Y, Yang D, et al. Predictive value of primary gross tumor volume measured by MRI in response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Journal of Applied Clinical Medical Physics. 2026. doi:10.1002/acm2.70601

BibTeX
@article{Li2026,
  author = {Li, Junbiao and Wu, Yuduo and Ye, Shaoping and Fan, Cuiying and Lin, Yanping and Yang, Dianhua and Xia, Xiaoyi and Kang, Yajing and Liu, Dehao and Wu, Junxin},
  title = {Predictive value of primary gross tumor volume measured by MRI in response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2026},
  doi = {10.1002/acm2.70601}
}
Kostenlos starten →